Westfield, NJ, United States of America

Richard D Tillyer


Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Scotch Plains, NJ (US) (1996)
  • Westfield, NJ (US) (1998 - 2002)
  • Cranford, NJ (US) (1999 - 2003)

Company Filing History:


Years Active: 1996-2003

Loading Chart...
23 patents (USPTO):

Title: Innovator Spotlight: Richard D. Tillyer

Introduction: Richard D. Tillyer, based in Westfield, NJ, is a prolific inventor with an impressive portfolio of 23 patents to his name. His contributions primarily lie within the pharmaceutical and chemical industries, focusing on innovations that target critical biological processes for therapeutic benefits.

Latest Patents: Among Tillyer's latest inventions is a patent for "Dihydroxy Open-Acid and Salts of HMG-CoA Reductase Inhibitors." This invention details methods and pharmaceutical compositions designed to inhibit HMG-CoA reductase, which is essential in treating diseases related to cholesterol management. By employing a delayed-release pharmaceutical dosage form, Tillyer's invention ensures that active compounds provide their beneficial effects after passing through the stomach, maximizing potency and effectiveness. Additionally, he has worked on the "Synthesis of Ketosulfone Esters," showcasing his versatility and technical expertise in chemical synthesis.

Career Highlights: Richard Tillyer's career has seen him collaborate with leading companies in the pharmaceutical sector, most notably Merck & Company, Inc. and Merck Frosst Canada & Co. His work in these organizations has significantly contributed to the advancement of drug development processes and the creation of innovative therapies that address pressing health issues.

Collaborations: Throughout his career, Tillyer has also worked alongside notable colleagues, including David M. Tschaen and Lisa F. Frey. These collaborations have fostered an environment of shared knowledge and expertise, enabling the development of groundbreaking inventions that have the potential to transform the pharmaceutical landscape.

Conclusion: Richard D. Tillyer's contributions to the field of pharmaceutical innovation exemplify the impact of inventive thinking in addressing global health challenges. With a robust portfolio of patents and significant industry collaborations, Tillyer continues to be a vital figure in the advancement of therapeutic solutions. His inventions not only reflect his expertise but also signify the importance of innovation in improving human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…